Add
ABPI to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| ABPI > SEC Filings for ABPI > Form 8-K on 23-May-2008 | All Recent SEC Filings |
23-May-2008
Notice of Delisting or Failure to Satisfy a Continued Listing Rul
On May 21, 2008, Accentia Biopharmaceuticals, Inc. (the "Company") received notice from the Listing Qualifications Department of The NASDAQ Stock Market indicating that the Company has been approved to list its common stock on The NASDAQ Capital Market. The Company's common stock will begin trading on The NASDAQ Capital Market, and will cease trading on The NASDAQ Global Market, at the opening of business on May 23, 2008. The trading symbol for the Company's common stock remains "ABPI."
The following information is being furnished under Item 7.01 of Form 8-K a Press release, dated May 23, 2008 entitled "Accentia Transfers Listing to NASDAQ Capital Market", by the Company announcing the transfer of the listing of the Company's common stock from the NASDAQ Global Market to the NASDAQ Capital Market. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K;
This Current Report on Form 8-K sets forth statements that are not strictly historical in nature and such statements are referred to as "forward-looking statements." The forward-looking statements in this Form 8-K include statements about our product development programs, clinical trials for our SinuNase product and potential future market opportunity. Such forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results to be materially different from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to the progress, timing, cost, and results of Accentia's clinical trials and product development programs. All forward looking statements in this Form 8-K are qualified in their entirety by this cautionary statement, and we undertake no obligation to revise or update this news release to reflect events or circumstances after the date hereof.
See the Exhibit Index set forth below for a list of exhibits included with this Form 8-K.
|
|